methylphenidate HCl ERCT

DRUG2 trials

Sponsors

Pfizer

Conditions

Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity Disorder (ADHD)

Phase 4

Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.

WithdrawnNCT03546400

PfizerAttention Deficit Hyperactivity Disorder (ADHD)

Start: 2018-09-25End: 2020-12-03Updated: 2018-11-01

A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.

WithdrawnNCT03580005

PfizerAttention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD)

Start: 2018-10-31End: 2021-10-12Updated: 2018-11-01